CADTH lecture series – Dr. Jeffrey Hoch

CADTH is hosting a series of lectures by prominent scholars and opinion leaders to share their perspectives on some of ...

Read more →

RFP - Supply of contraceptive implants

[:content [\1 \7 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \P \H \A \R \M \A \C \space \i \n \v \i \t \e \s \space \p \r \o \p \o \s \a \l \s \space \f \o \r \space \t \h \e \space \s \u \p \p \l \y \space \o \f \space \c \o \n \t \r \a \c \e \p \t \i \v \e \space \i \m \p \l \a \n \t \s \space \i \n \space \N \e \w \space \Z \e \a \l \a \n \d \. " ..."]]
Read more →

Fury over cancer setback: Scots denied wonder drug that extends life up to five years

A drug used to treat women with the form of cancer that led Angelina Jolie to have her ovaries removed has been ...

Read more →

Summary of the agenda for the PBAC March 2014 meeting

[:content [\T \h \e \space \P \B \A \C \space \w \i \l \l \space \c \o \n \s \i \d \e \r \space \5 \3 \space \s \u \b \m \i \s \s \i \o \n \s \space \( \3 \1 \m \a \j \o \r \space \& \space \2 \2 \space \m \i \n \o \r \) \space \a \t \space \i \t \s \space \n \e \x \t \space \s \c \h \e \d \u \l \e \d \space \m \e \e \t \i \n \g \space \i \n \space \M \a \r \c \h \. \  " ..."]]
Read more →

Statement from the Chair of the Pharmaceutical Benefits Advisory Committee on eculizumab (Soliris)

As PBAC Chair I am deeply concerned by Alexion’s response to the Minister’s approval of funding for Soliris for the ...

Read more →

Insiders say NICE is being encouraged to be more favourable to industry

Committees of the UK National Institute for Health and Care Excellence (NICE) are being encouraged to be more favourable to ...

Read more →

NICE recommends ustekinumab (Stelara) for psoriatic arthritis

NICE has published final guidance recommending ustekinumab (Stelara) as a treatment option for psoriatic arthritis in certain circumstances.  ...

Read more →

GSK announces approval in Canada for Incruse Ellipta (umeclidinium bromide) as a treatment for COPD

[:content [\1 \7 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \  \G \S \K \space \t \o \d \a \y \space \a \n \n \o \u \n \c \e \d \space \t \h \a \t \space \I \n \c \r \u \s \e \  \E \l \l \i \p \t \a \  \( \u \m \e \c \l \i \d \i \n \i \u \m \space \b \r \o \m \i \d \e \) \space \h \a \s \space \r \e \c \e \i \v \e \d \space \m \a \r \k \e \t \space \a \u \t \h \o \r \i \s \a \t \i \o \n \space \i \n \space \C \a \n \a \d \a \space \f \o \r \space \t \h \e \space \l \o \n \g \- \t \e \r \m \space \o \n \c \e \- \d \a \i \l \y \space \m \a \i \n \t \e \n \a \n \c \e " ..."]]
Read more →

Decision criteria consultation – proposal for change

[:content [\1 \8 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \P \H \A \R \M \A \C \space \i \s \space \s \e \e \k \i \n \g \space \f \e \e \d \b \a \c \k \space \o \n \space \t \h \e \space \c \r \i \t \e \r \i \a \space \i \t \space \u \s \e \s \space \t \o \space \m \a \k \e \space \d \e \c \i \s \i \o \n \s \. \space \Y \o \u \space \c \a \n \space \h \a \v \e \space \y \o \u \r \space \s \a \y " ..."]]
Read more →

MAESTrO - Now housed on local server

[:content [\4 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \space \T \h \e \space \M \A \E \S \T \r \O \space \d \a \t \a \b \a \s \e \space \i \s \space \n \o \w \space \h \o \u \s \e \d \space \o \n \space \a \space \l \o \c \a \l \space \s \e \r \v \e \r \. \space \S \u \b \s \c \r \i \b \e \r \s \space \s \h \o \u \l \d \space \n \o \t \i \c \e \space \a \space \s \i \g \n \i \f \i \c \a \n \t \  \i \m \p \r \o \v \e \m \e \n \t \space \i \n " ..."]]
Read more →

NICE consults on the use of a new lung cancer drug

NICE, the healthcare guidance body, has issued new draft guidance not recommending nintedanib (also known as Vargatef) for the treatment ...

Read more →

Protalix announces Elelyso (taliglucerase alfa) approved in Australia for the treatment of Gaucher disease in both adult and paediatric patients

22 May 2014 - Protalix BioTherapeutics, Inc. announced today that the Australian Therapeutic Goods Administration (TGA) has granted regulatory approval to Elelyso (taliglucerase alfa) for long-term enzyme ...

Read more →

Investors bet $100,000 cancer drug prices are here to stay

President Barack Obama, prominent cancer doctors and health insurers are all warning about the need to control the surging prices ...

Read more →

BC cancer agency adds Kadcyla to the provincial formulary for the treatment of HER2-positive metastatic breast cancer

Women with HER2-positive metastatic breast cancer in British Columbiawill now be able to access a new treatment option through the BC ...

Read more →

Germany's IQWiG finds some benefit in Eisai's Halaven (eribulin mesylate)

Germany’s IQWiG has concluded that Eisai’s breast cancer drug Halaven (erbulin mesylate) does indeed offer a benefit over other comparators on ...

Read more →